Nipent (Hospira, Inc.)
Welcome to the PulseAid listing for the Nipent drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | PENTOSTATIN |
SUBSTANCE NAME: | PENTOSTATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-08-15 |
END MARKETING DATE: | 0000-00-00 |
Nipent HUMAN PRESCRIPTION DRUG Details:
Item Description | Nipent from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2007-08-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-0801_2d0f427c-d5be-43e6-ae24-66cfb77ba2b9 |
PRODUCT NDC: | 0409-0801 |
APPLICATION NUMBER: | NDA020122 |
Other PENTOSTATIN Pharmaceutical Manufacturers / Labelers: